rituximab,bendamustine,lenalidomide
teva
['lymphoma', 'rebel', 'hovon110,rebel ']
r2 vs benda-r2 in r/r fl ph 2 hovon110/rebel ct although severe aes were higher with benda it had an acceptable safety profile when ab prophylaxis data support r2 combination studies, with the focus on achieving cmr at the end of induction by #lymphoma #ash22 
Medical degree at @USAL | Internal Medicine student at @HematoCAUSA | Hematology and Hemotherapy at Hospital Ramón y Cajal @HematoRYC | PhD student at @UAHes